Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose randomized, double-blind, placebo-controlled study of AMG 827 in rheumatoid arthritis
2009-012566-32Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing AMG 827 with Placebo (2 arms). Primary endpoint: ACR 50 response at Week 12. Started Oct 2009; status: completed.
02
Drugs
brodalumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-012566-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012566-32.